March MIMS update

antibiotics pills medicines
We look at some of the recent changes to the medicines landscape, with new products, indications and contraindications New Products Nirsevimab (Beyfortus) is a recombinant neutralising human IgG1ĸ long-acting monoclonal antibody to the prefusion conformation of the respiratory syncytial virus (RSV) F protein which has been modified with a triple amino acid substitution (YTE) in

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Forgot Password?Why do I need to login & stay in?

Previous Residents beg for walkable pharmacy after rejection
Next Docs demand pharmacy rules Bill rejection